knowledge -WSS

knowledge

author：hotspot 2025-08-12 08:25:54 - browse：25865

Illumina, the leading maker of DNA sequencing machines, said Sunday that it would divest Grail, the developer of a multi-cancer screening test, which it bought over the objections of regulators in the U.S. and Europe in August 2021.

Illumina said the decision to spin Grail off followed a Friday decision of the U.S. Fifth Circuit Court of Appeals, which held that the merger was anti-competitive. It said that it would divest Grail either by selling it to another company or listing it on capital markets, consistent with an order from the European Commission, and that it aims to finalize the terms of the deal by the end of the second quarter of 2024.

The decision opens what should be the final chapter in one of the most disastrous attempted mergers in biotech history. Illumina, a storied name that had delivered investors strong returns over two decades, spun out Grail in 2016 in order to raise money to fund the company’s work. Then, it announced plans to re-acquire the firm for $7.1 billion in Sept. 2020.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Rep. Raul Ruiz on the physician shortage and more

Wikipedia

explore

WSS

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

Noem? Reynolds? A very early look at the Republican 'veepstakes'

Pediatric cancer treatments threatened by a new FDA policy

Masked assailants attack a journalist and a lawyer in Russia's Chechnya province

Will the market for weight loss drugs really reach $100 billion?

Pediatric cancer treatments threatened by a new FDA policy

explore

knowledge

entertainment

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Elon Musk announces 'temporary limits' for reading Twitter posts

State Dept. review finds Biden bears some blame for Afghanistan failures

Masked assailants attack a journalist and a lawyer in Russia's Chechnya province

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Chicago flooding is stark reminder of vulnerability of major cities during extreme weather

Medicare proposal to cover medical devices draws a mixed reaction

Flagship Pioneering launches a new biotech in two countries

Activists slam private health insurers over coverage restrictions

1 dead, 9 hurt in July 4th fireworks explosion

focus

Legitimacy of 'customer' in Supreme Court gay rights case raises ethical, legal flags

Palestinian attacker wounds 8 in Tel Aviv as Israel presses on with West Bank operation

U.K. Biobank has 500,000 peoples' genome sequences available

Mayo Clinic plans $5B tech

Churchill Downs extends trainer Bob Baffert's ban through 2024

What don’t we know about an Alzheimer’s drug side effect?

entertainment

Wikipedia

explore

explore